Stocks-WST-West Pharmaceutical Services Inc

WST West Pharmaceutical Services Inc

0 0 (0%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2022: West Pharmaceutical Services Inc's revenues increased by 1.95% and amounted to 2.89B. Net income decreased by 11.47% to 585.90M. Net assets increased by 21.61% to 1.39B and EPS decreased from 8.67 to 7.73.
WST's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
38.13%
Net Profit Margin
18.23%
Operating Margin
24.19%
Return On Investment
18.44%